Toolkit/p21-CRY2/CIB1

p21-CRY2/CIB1

Multi-Component Switch·Research·Since 2023

Also known as: cryptochrome 2/CIBN p21 fusion system

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

p21-CRY2/CIB1 is a blue-light-responsive optogenetic p21 system built by fusing p21 to the cryptochrome 2/CIBN switch components. It was used to control p21 subcellular localization and nuclear function and increased the fraction of cells arrested in G1 phase.

Usefulness & Problems

Why this is useful

This system provides light-dependent control over the localization-dependent activity of the cyclin-dependent kinase inhibitor p21. The cited study further proposed its application in producer cell lines to uncouple proliferation from G1 arrest for biotherapeutic protein production.

Source:

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.

Source:

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.

Problem solved

It addresses the need for externally controllable regulation of p21 function, specifically its subcellular localization and nuclear activity. The reported implementation also targets controlled induction of G1 cell cycle arrest.

Source:

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Techniques

No technique tags yet.

Target processes

localizationrecombination

Input: Light

Implementation Constraints

The system was generated through fusions of p21 with the blue-light switch cryptochrome 2/CIBN, indicating a multi-component construct design. The provided evidence does not specify exact fusion topology, expression system, light dose, or any required cofactors.

The supplied evidence is limited to a single 2023 study and does not provide quantitative performance metrics, kinetics, reversibility, or cell-type breadth. Practical details of construct architecture, illumination parameters, and comparative performance against other optogenetic p21 designs are not given in the provided evidence.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 2application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 3application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 4application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 5application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 6application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 7application potentialsupports2023Source 1needs review

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
Claim 8cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 9cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 10cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 11cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 12cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 13cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 14cell cycle arrestsupports2023Source 1needs review

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase
Claim 15functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 16functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 17functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 18functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 19functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 20functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 21functional effectsupports2023Source 1needs review

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.
Claim 22productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 23productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 24productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 25productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 26productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 27productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 28productivity effectsupports2023Source 1needs review

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.
Claim 29tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.
Claim 30tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.
Claim 31tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.
Claim 32tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.
Claim 33tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.
Claim 34tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.
Claim 35tunabilitysupports2023Source 1needs review

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.

Approval Evidence

1 source5 linked approval claimsfirst-pass slug p21-cry2-cib1
To generate light-controllable p21, appropriate fusions with the blue light switch cryptochrome 2/CIBN ... were used. Both systems, p21-CRY2/CIB1 and p21-LINuS...

Source:

application potentialsupports

Light-controllable p21 in producer cell lines could be applied to uncouple cell proliferation from G1 cell cycle arrest to optimize biotherapeutic protein production.

Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.

Source:

cell cycle arrestsupports

Both p21-CRY2/CIB1 and p21-LINuS increased the amount of cells arrested in the G1 phase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase

Source:

functional effectsupports

Optogenetically controlled p21 systems were used to control the subcellular localization and nuclear functions of p21.

Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions.

Source:

productivity effectsupports

The increase in G1-arrested cells correlated with increased cell-specific productivity of secreted alkaline phosphatase.

Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase.

Source:

tunabilitysupports

Blue LED exposure interval and light dose enabled fine-tuning of the optogenetic p21 systems.

Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems.

Source:

Comparisons

Source-backed strengths

The tool is responsive to blue light and was experimentally used to regulate p21 localization and nuclear functions. In the cited work, p21-CRY2/CIB1 increased the proportion of cells arrested in G1 phase.

Ranked Citations

  1. 1.
    StructuralSource 1Biology2023Claim 1Claim 2Claim 3

    Extracted from this source document.